文献速递心外重症与机械循环支持

急性肾损伤患者植入左心室辅助装置后的结局

Outcomes after left ventricular assist device implantation in patients with acute kidney injury.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-04-04

基于2008至2013年美国全国住院患者样本,8362例植入左心室辅助装置的患者中,45.0%发生非透析急性肾损伤,5.1%发生需透析急性肾损伤。非透析急性肾损伤患者院内死亡率为12.2%,需透析急性肾损伤患者为47.4%,均显著高于无急性肾损伤患者的3.9%。需透析急性肾损伤患者仅30%出院回家。

要点

  • 植入左心室辅助装置患者中非透析急性肾损伤占45.0%,需透析急性肾损伤占5.1%。
  • 需透析急性肾损伤患者院内死亡率高达47.4%,仅30%出院回家。
  • 非透析急性肾损伤和需透析急性肾损伤均与死亡、大出血、脓毒症及出院至护理机构风险升高相关。

核心结论

  • 急性肾损伤患者植入左心室辅助装置后院内死亡和并发症风险显著升高,需透析者尤为严重。
  • 超过十分之一的急性肾损伤患者和约一半的需透析急性肾损伤患者住院期间死亡。
  • 仅30%的需透析急性肾损伤患者出院回家。

研究设计与样本

  • 使用2008至2013年美国全国住院患者样本(National Inpatient Sample)的回顾性队列研究。
  • 通过国际疾病分类第九版手术操作代码37.66识别左心室辅助装置植入患者,共8362例。
  • 使用经验证的国际疾病分类第九版代码判定急性肾损伤及需透析急性肾损伤。
  • 采用逻辑回归分析非透析急性肾损伤和需透析急性肾损伤与死亡率、手术并发症及出院去向的关联。

主要发现

  • 8362例患者中,3760例(45.0%)发生非透析急性肾损伤,426例(5.1%)发生需透析急性肾损伤。
  • 院内死亡率:无急性肾损伤患者3.9%,非透析急性肾损伤患者12.2%,需透析急性肾损伤患者47.4%。
  • 非透析急性肾损伤与需透析急性肾损伤的调整死亡比值比分别为3.24(95%CI 2.04-5.13)和20.8(95%CI 9.7-44.2)。
  • 非透析急性肾损伤与需透析急性肾损伤的大出血调整比值比分别为1.38(95%CI 1.08-1.77)和2.44(95%CI 1.47-4.04)。
  • 非透析急性肾损伤与需透析急性肾损伤的脓毒症调整比值比分别为2.69(95%CI 1.93-3.75)和5.75(95%CI 3.46-9.56)。

临床怎么用

  • 对晚期心力衰竭合并急性肾损伤患者植入左心室辅助装置前,应充分告知死亡和并发症风险以支持共享决策。
  • 需透析急性肾损伤患者植入左心室辅助装置后死亡风险极高,需强化围术期管理和并发症预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to compare outcomes for patients with and without acute kidney injury during hospitalizations when left ventricular assist devices are implanted. METHODS: By using the National Inpatient Sample from 2008 to 2013, we identified patients with an International Classification of Diseases, Ninth Revision procedure code for left ventricular assist device implantation (37.66). We ascertained the presence of acute kidney injury and acute kidney injury requiring dialysis using validated International Classification of Diseases, Ninth Revision codes. We used logistic regression to examine the association of nondialysis-requiring acute kidney injury and acute kidney injury requiring dialysis with mortality, procedural complications, and discharge destination. RESULTS: We identified 8362 patients who underwent left ventricular assist device implantation, of whom 3760 (45.0%) experienced nondialysis-requiring acute kidney injury and 426 (5.1%) experienced acute kidney injury requiring dialysis. In-hospital mortality was 3.9% for patients without acute kidney injury, 12.2% for patients with nondialysis-requiring acute kidney injury, and 47.4% for patients with acute kidney injury requiring dialysis. Patients with nondialysis-requiring acute kidney injury and acute kidney injury requiring dialysis had higher adjusted odds of mortality (3.24, 95% confidence interval [CI], 2.04-5.13 and 20.8, 95% CI, 9.7-44.2), major bleeding (1.38, 95% CI, 1.08-1.77 and 2.44, 95% CI, 1.47-4.04), sepsis (2.69, 95% CI, 1.93-3.75 and 5.75, 95% CI, 3.46-9.56), and discharge to a nursing facility (2.15, 95% CI, 1.51-3.07 and 5.89, 95% CI, 2.67-12.99). CONCLUSIONS: More than 1 in 10 patients with acute kidney injury and approximately 1 in 2 patients with acute kidney injury requiring dialysis died during their hospitalization, with only 30% of patients with acute kidney injury requiring dialysis discharged to home. This information is necessary to support shared decision-making for patients with advanced heart failure and acute kidney injury.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Silver SA, Long J, Zheng Y, et al. Outcomes after left ventricular assist device implantation in patients with acute kidney injury. J Thorac Cardiovasc Surg. 2019. PMID: 31053433. doi:10.1016/j.jtcvs.2019.03.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。